Dynavax to Present at the 34th Annual Cowen & Company Health Care Conference

Dynavax to Present at the 34th Annual Cowen & Company Health Care Conference 
BERKELEY, CA -- (Marketwired) -- 02/28/14 --  Dynavax Technologies
Corporation (NASDAQ: DVAX) announced today that it will present at
the 34th Annual Cowen & Company Health Care Conference in Boston on
Tuesday, March 4, 2014 at 10:00 a.m. Eastern Time (7:00 a.m. Pacific
Time).  
Eddie Gray, Chief Executive Officer of Dynavax, will provide a
company overview. To access the slide presentation, live webcast, and
subsequent archived recording, please visit Dynavax's website at
http://investors.dynavax.com/newsevents.cfm.  
About Dynavax
 Dynavax, a clinical-stage biopharmaceutical company,
discovers and develops novel vaccines and therapeutics in the areas
of infectious and inflammatory diseases and oncology. Dynavax's lead
product candidate is HEPLISAV-B, a Phase 3 investigational adult
hepatitis B vaccine. For more information visit www.dynavax.com. 
Contact:
Michael Ostrach
Vice President and Chief Business Officer 
510-665-7257
mostrach@dynavax.com 
 
 
Press spacebar to pause and continue. Press esc to stop.